These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

858 related items for PubMed ID: 25230094

  • 1. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
    Lim HW, Grimes PE, Agbai O, Hamzavi I, Henderson M, Haddican M, Linkner RV, Lebwohl M.
    JAMA Dermatol; 2015 Jan; 151(1):42-50. PubMed ID: 25230094
    [Abstract] [Full Text] [Related]

  • 2. The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo.
    Grimes PE, Hamzavi I, Lebwohl M, Ortonne JP, Lim HW.
    JAMA Dermatol; 2013 Jan; 149(1):68-73. PubMed ID: 23407924
    [Abstract] [Full Text] [Related]

  • 3. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS, Palmer RA, Garibaldinos TM, Hawk JL.
    Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
    [Abstract] [Full Text] [Related]

  • 4. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index.
    Hamzavi I, Jain H, McLean D, Shapiro J, Zeng H, Lui H.
    Arch Dermatol; 2004 Jun; 140(6):677-83. PubMed ID: 15210457
    [Abstract] [Full Text] [Related]

  • 5. Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT.
    Batchelor JM, Thomas KS, Akram P, Azad J, Bewley A, Chalmers JR, Cheung ST, Duley L, Eleftheriadou V, Ellis R, Ferguson A, Goulding JM, Haines RH, Hamad H, Ingram JR, Laguda B, Leighton P, Levell N, Makrygeorgou A, Meakin GD, Millington A, Ogboli M, Rajasekaran A, Ravenscroft JC, Rogers A, Sach TH, Santer M, Stainforth J, Tan W, Wahie S, White J, Whitton ME, Williams HC, Wright A, Montgomery AA.
    Health Technol Assess; 2020 Nov; 24(64):1-128. PubMed ID: 33245043
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas.
    Vachiramon V, Chaiyabutr C, Rattanaumpawan P, Kanokrungsee S.
    Lasers Surg Med; 2016 Feb; 48(2):197-202. PubMed ID: 26175036
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Afamelanotide implants and narrow-band ultraviolet B phototherapy for the treatment of nonsegmental vitiligo in Asians.
    Toh JJH, Chuah SY, Jhingan A, Chong WS, Thng STG.
    J Am Acad Dermatol; 2020 Jun; 82(6):1517-1519. PubMed ID: 31987791
    [No Abstract] [Full Text] [Related]

  • 10. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
    Asawanonda P, Klahan SO.
    Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical evaluation of interrupted versus continuous narrowband ultraviolet B phototherapy in nonsegmental vitiligo treatment: A prospective randomized comparative study.
    Anbar TS, Mohammed SS, Mohamed DM, Abdel-Rahman AT.
    Dermatol Ther; 2019 Nov; 32(6):e13117. PubMed ID: 31606939
    [Abstract] [Full Text] [Related]

  • 13. Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study.
    Asawanonda P, Kijluakiat J, Korkij W, Sindhupak W.
    Acta Derm Venereol; 2008 Nov; 88(4):376-81. PubMed ID: 18709309
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
    Esfandiarpour I, Ekhlasi A, Farajzadeh S, Shamsadini S.
    J Dermatolog Treat; 2009 Nov; 20(1):14-8. PubMed ID: 18608735
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Whole-body and targeted narrowband ultraviolet B phototherapy effectively stabilize acral vitiligo with negligible repigmentation beyond wrists and ankles: Results from a split-body randomized controlled trial.
    Thind A, Vinay K, Mehta H, Bishnoi A, Kumaran MS, Parsad D.
    Photodermatol Photoimmunol Photomed; 2024 Mar; 40(2):e12960. PubMed ID: 38480997
    [Abstract] [Full Text] [Related]

  • 20. Comparison of efficacy and safety profile of topical calcipotriol ointment in combination with NB-UVB vs. NB-UVB alone in the treatment of vitiligo: a 24-week prospective right-left comparative clinical trial.
    Khullar G, Kanwar AJ, Singh S, Parsad D.
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):925-32. PubMed ID: 25220387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.